Compounded Semaglutide GLP-1 Weight Loss in Atlanta

Most side effects, such as nausea, are mild and often resolve within a few days to weeks as the body adjusts to the medication. Our team will help you manage any side effects you may experience, making adjustments to minimize discomfort throughout your treatment. Additionally, we provide guidance on lifestyle and dietary changes that can help reduce side effects and improve comfort during treatment.

While Compounded Semaglutide is not FDA-approved, the active ingredient — Semaglutide — is FDA-approved in branded medications for weight management and obesity.

At Vital Living Healthcare, we source Compounded Semaglutide from reputable 503A and 503B compounding pharmacies that meet strict quality and safety standards.

Dr. Cox oversees every stage of treatment so you receive the highest standard of safety and effectiveness. We offer regular check-ins, adjustments, and comprehensive patient education on managing potential side effects. Our goal is a smooth and effective weight loss journey.

No. Ozempic is a brand name for Semaglutide used to treat diabetes, while Wegovy, a higher-dose form of Semaglutide, is specifically approved for weight loss.

Ozempic is a patent protected formula of Semaglutide that can only be marketed and sold by Novo-Nordisk, the patent holder.

Compounded Semaglutide has the same active ingredient as the name brand medications. However, there have been no head-to-head studies to confirm that they are equally effective. Both work by activating the GLP-1 receptor, which helps regulate blood sugar, curb appetite, and promote a feeling of fullness. While the active ingredient is the same the exact makeup of the patented, name brand drugs is unknown so the inactive ingredients will most likely be different on the compounded version. At Vital Living Healthcare, we use certified 503A and 503B pharmacies to ensure safety, quality, and effectiveness in all of our prescribed compounded medications.

Our results speak for themselves: With over 700 patients actively enrolled in our medical weight loss program, we’re seeing an average weight loss of 12–34% in just six months. This compares favorably to the 14-21% weight loss seen with the clinical trials for GLP-1 medications containing Semaglutide and Tirzepatide. This isn’t just about shedding pounds — it’s about transforming health, adding muscle mass, improved energy, and changing how we look at food under the guidance of our physician-led weight loss program.

The duration of semaglutide treatment depends on individual progress and goals. Most patients remain on the medication for a few months to a year, with adjustments made based on results. Vital Living Healthcare will work with you to determine the best treatment plan for sustainable results. Your individual treatment duration will align with your health needs and lifestyle.

Semaglutide is commonly injected into the abdomen but can also be administered in the thigh or upper arm.

Our team will guide you through the process, teaching you how to safely and confidently perform the injections at home. We ensure you feel comfortable and equipped to incorporate this step seamlessly into your routine, addressing any questions or concerns along the way.

Unfortunately, most health insurers do not cover the treatment of weight loss or obesity medications. To find out if you have coverage contact your benefits administrator at your workplace or check the formulary (list of approved medications for your particular health plan) online.

Even if you meet the treatment criteria established by the guidelines to take the medication, your health insurance can choose not to cover the medication, or you can be “covered” with copays up to $900 per month in our patients’ experience.

If you pay the MSRP for Wegovy or Ozempic it will cost you anywhere from $900 to $1300/month or more. That is why we utilize the compounded version and can provide you with the medication regardless of dosage for $299 per month.

You should not take Compounded Semaglutide or other GLP-1 medications if you:

• are currently pregnant or breastfeeding
• have a personal or family history of medullary thyroid cancer or
• have a personal or family history of multiple endocrine neoplasia syndrome type 2
• have been diagnosed with Gastroparesis (a stomach motility disorder)

Additionally, if you have taken Ozempic, Wegovy, or Rybelsus in the past and did not tolerate them you should not use Compounded Semaglutide. If you develop a rash around the injection site, alert your medical practitioner immediately and stop treatment.

If you are unwilling to change your lifestyle of unhealthy food choices or amounts, this medication will not be effective in the long term. There are many other reasons GLP-1 treatments may not be suitable for all persons; ask your doctor or NP if you need more information.